Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Berry Genetics is a private California agricultural genetics company focused on breeding, protecting, licensing, and distributing proprietary berry cultivars, especially short-day strawberry varieties and more recently blueberry varieties. Its business centers on plant breeding, nursery and propagation relationships, intellectual property protection, and crop consulting rather than human therapeutics or healthcare products. The company serves growers worldwide in Mediterranean and other suitable climate zones, with capabilities spanning varietal development, agronomic support, pest management advice, and licensing. Based on available public information, Berry Genetics is an active agritech company, not a life science, biotech, pharma, or healthcare company in the human health sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Berry Genetics.